Pierre F Sabouret Shares A Study on the Risk of Cardiovascular Death in SIDs
Pierre F Sabouret, Member of the Executive Committee for Education at European Atherosclerosis Society, shared on LinkedIn:
”On pubmed today.
Number 28 in 2025 (same result as in 2024 reached in the last days of the year).
Grateful to have some friends to publish interesting (at least in my view) topics.”
This systematic review and meta-analysis of 39 observational studies involving 171,748 patients found that systemic immune-mediated diseases (SIDs) were associated with a significantly increased risk of cardiovascular death.
The association was particularly strong in patients with rheumatoid arthritis, systemic lupus erythematosus, and granulomatosis with polyangiitis, and was more pronounced among women.
Most cardiovascular deaths were attributable to acute coronary syndrome, with a 34% higher risk observed in SID patients.
Despite substantial heterogeneity and the observational nature of the data, the findings highlight the need for improved cardiovascular risk assessment in these populations.
Read the full article here.
Article: The risk of cardiovascular death in systemic immune-mediated diseases: A systematic review and meta-analysis
Authors: Stefano Figliozzi, Thanakorn Rojanathagoon, Spyridoula Karogianni, Lorenzo Cambini, Marco Bernardi, Cristina Panico, Fabrizio Ricci, Maria De Santis, Antonio Cannatà, Marinos Kallikourdis, Sebastiano Sciarretta, Giulio Stefanini, Mamas A. Mamas, Gianluigi Condorelli, Pierre F. Sabouret, Georgios Georgiopoulos
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 26, 2026, 17:52Kamlesh Darji: A Practical Guide to Interpreting Coagulation Tests
-
Aug 26, 2026, 17:46Bruno Pougault: The Hidden Burden of Hemostatic Disorders in Women
-
Aug 26, 2026, 17:39Charan Gubba: Adult ITP – A major shift in the 2026 ASH Guidelines
-
Aug 26, 2026, 17:38Stephan A Mayer: Early Imaging Reveals Higher Risk of Hematoma Expansion After ICH
-
Aug 26, 2026, 17:09Kemal Karaagac: NOACs May Offer Cognitive and Clinical Benefits in AF With Alzheimer’s Disease
-
Aug 26, 2026, 16:53Chokri Ben Lamine: Antiphospholipid Syndrome After Kidney Transplantation
-
Aug 26, 2026, 16:32Kai Rejeski: Why TP53 Mutations May Define a Higher-Risk CAR-T Population
-
Aug 26, 2026, 16:20Ons Marsit: Impact of Electroanatomical Mapping on Pentaspline Pulsed Field Ablation
-
Aug 26, 2026, 16:18Sam Mbunya: Celebrating Cyrus Njuguna Githinji’s New Leadership Role in Haemophilia Care